{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T23:35:51Z","timestamp":1792884951416,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00210-026-05658-2","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T06:23:11Z","timestamp":1782973391000},"page":"20359-20373","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Role of CXCL16\/ADAM10 signaling in methotrexate-induced nephrotoxicity and its modulation by simvastatin"],"prefix":"10.1007","volume":"399","author":[{"given":"Alulu","family":"Alradhi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahman A.","family":"Alelowi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad H.","family":"Alhowail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha A.","family":"Aldubayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed S.","family":"Abdel-Bakky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"key":"5658_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3897\/PHARMACIA.71.E137797","volume":"71","author":"MS Abdel-Bakky","year":"2024","unstructured":"Abdel-Bakky MS, Mohammed HA, Amin E (2024) Inhibition of selective factor Xa suppresses type 1 diabetes development in mice via the CXCL16 chemokine. Pharmacia 71:1\u201310. https:\/\/doi.org\/10.3897\/PHARMACIA.71.E137797","journal-title":"Pharmacia"},{"key":"5658_CR2","doi-asserted-by":"publisher","first-page":"481","DOI":"10.5937\/jomb0-25120","volume":"39","author":"PL Abdel-Messeih","year":"2020","unstructured":"Abdel-Messeih PL, Alkady MM, Nosseir NM, Tawfik MS (2020) Inflammatory markers in end-stage renal disease patients on haemodialysis. J Med Biochem 39:481\u2013487. https:\/\/doi.org\/10.5937\/jomb0-25120","journal-title":"J Med Biochem"},{"key":"5658_CR3","doi-asserted-by":"publisher","DOI":"10.1080\/13510002.2023.2270886","author":"WM Abdel-Wahab","year":"2023","unstructured":"Abdel-Wahab WM, Daifalla NS, Essawy AE (2023) L-methionine protects against nephrotoxicity induced by methotrexate through modulation of redox status and inflammation. Redox Rep. https:\/\/doi.org\/10.1080\/13510002.2023.2270886","journal-title":"Redox Rep"},{"key":"5658_CR4","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.10.6362","author":"S Abel","year":"2004","unstructured":"Abel S, Hundhausen C, Mentlein R et al (2004) The transmembrane CXC-chemokine ligand 16 is induced by IFN-\u03b3 and TNF-\u03b1 and shed by the activity of the disintegrin-like metalloproteinase ADAM10. J Immunol. https:\/\/doi.org\/10.4049\/jimmunol.172.10.6362","journal-title":"J Immunol"},{"key":"5658_CR5","doi-asserted-by":"publisher","first-page":"457","DOI":"10.21608\/aps.2023.232811.1134","volume":"7","author":"A Algendy","year":"2023","unstructured":"Algendy A, Mantawy E, Tadros M, Helal G (2023) Methotrexate induced nephrotoxicity: possible underlying mechanisms and promising natural protective agents in experimental models. Arch Pharm Sci Ain Shams Univ 7:457\u2013469. https:\/\/doi.org\/10.21608\/aps.2023.232811.1134","journal-title":"Arch Pharm Sci Ain Shams Univ"},{"key":"5658_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-024-03164-x","author":"GF Ali","year":"2024","unstructured":"Ali GF, Hassanein EHM, Mohamed WR (2024) Molecular mechanisms underlying methotrexate-induced intestinal injury and protective strategies. Naunyn Schmiedebergs Arch Pharmacol. https:\/\/doi.org\/10.1007\/s00210-024-03164-x","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"5658_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70516","author":"H Bing","year":"2025","unstructured":"Bing H, Ma Y, Xu J et al (2025) Impact of methotrexate and 7-hydroxymethotrexate exposure on renal toxicity in pediatric non-hodgkin lymphoma. Cancer Med. https:\/\/doi.org\/10.1002\/cam4.70516","journal-title":"Cancer Med"},{"key":"5658_CR8","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.3892\/mmr.2020.11292","volume":"22","author":"Y Chen","year":"2020","unstructured":"Chen Y, Wang Z, Li Q et al (2020) OxLDL promotes podocyte migration by regulating CXCL16, ADAM10 and ACTN4. Mol Med Rep 22:1976\u20131984. https:\/\/doi.org\/10.3892\/mmr.2020.11292","journal-title":"Mol Med Rep"},{"key":"5658_CR9","doi-asserted-by":"crossref","unstructured":"Dashti-Khavidaki S, Moghaddas A, Heydari B, et al (2013) Statins Against Drug-Induced Nephrotoxicity","DOI":"10.18433\/J3T30F"},{"key":"5658_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232112794","author":"MSEdin El-Agawy","year":"2022","unstructured":"El-Agawy MSEdin, Badawy AMM, Rabei MR et al (2022) Methotrexate-induced alteration of renal aquaporins 1 and 2, oxidative stress and tubular apoptosis can be attenuated by omega-3 fatty acids supplementation. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms232112794","journal-title":"Int J Mol Sci"},{"key":"5658_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jcbfm.9600116","author":"M Endres","year":"2005","unstructured":"Endres M (2005) Statins and stroke. J Cereb Blood Flow Metab. https:\/\/doi.org\/10.1038\/sj.jcbfm.9600116","journal-title":"J Cereb Blood Flow Metab"},{"key":"5658_CR12","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jare.2020.12.014","volume":"31","author":"MGED Ewees","year":"2021","unstructured":"Ewees MGED, Abdel-Bakky MS, Bayoumi AMA et al (2021) Dabigatran mitigates cisplatin-mediated nephrotoxicity through down regulation of thrombin pathway. J Adv Res 31:127\u2013136. https:\/\/doi.org\/10.1016\/j.jare.2020.12.014","journal-title":"J Adv Res"},{"key":"5658_CR13","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.2353\/ajpath.2007.060065","volume":"170","author":"GE Garcia","year":"2007","unstructured":"Garcia GE, Truong LD, Li P et al (2007) Inhibition of CXCL16 attenuates inflammatory and progressive phases of anti-glomerular basement membrane antibody-associated glomerulonephritis. Am J Pathol 170:1485\u20131496. https:\/\/doi.org\/10.2353\/ajpath.2007.060065","journal-title":"Am J Pathol"},{"key":"5658_CR14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.15171\/jnp.2017.02","volume":"6","author":"Z Goodarzi","year":"2016","unstructured":"Goodarzi Z, Karami E, Ahmadizadeh M (2016) Simvastatin attenuates chromium-induced nephrotoxicity in rats. J Nephropathol 6:5\u20139. https:\/\/doi.org\/10.15171\/jnp.2017.02","journal-title":"J Nephropathol"},{"key":"5658_CR15","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.6.3678","author":"PJ Gough","year":"2004","unstructured":"Gough PJ, Garton KJ, Wille PT et al (2004) A disintegrin and metalloproteinase 10-mediated cleavage and shedding regulates the cell surface expression of CXC chemokine ligand 16. J Immunol. https:\/\/doi.org\/10.4049\/jimmunol.172.6.3678","journal-title":"J Immunol"},{"key":"5658_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-023-03103-7","author":"J Guan","year":"2023","unstructured":"Guan J, Wang M, Zhao M et al (2023) Discovery of fibrinogen \u03b3-chain as a potential urinary biomarker for renal interstitial fibrosis in IgA nephropathy. BMC Nephrol. https:\/\/doi.org\/10.1186\/s12882-023-03103-7","journal-title":"BMC Nephrol"},{"key":"5658_CR17","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.2353\/ajpath.2009.080960","volume":"174","author":"P Gutwein","year":"2009","unstructured":"Gutwein P, Abdel-Bakky MS, Schramme A et al (2009) CXCL16 is expressed in podocytes and acts as a scavenger receptor for oxidized low-density lipoprotein. Am J Pathol 174:2061\u20132072. https:\/\/doi.org\/10.2353\/ajpath.2009.080960","journal-title":"Am J Pathol"},{"key":"5658_CR18","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.ajpath.2012.06.004","volume":"181","author":"D Hoffmann","year":"2012","unstructured":"Hoffmann D, Bijol V, Krishnamoorthy A et al (2012) Fibrinogen excretion in the urine and immunoreactivity in the kidney serves as a translational biomarker for acute kidney injury. Am J Pathol 181:818\u2013828. https:\/\/doi.org\/10.1016\/j.ajpath.2012.06.004","journal-title":"Am J Pathol"},{"key":"5658_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2006.11.073","author":"S I\u015feri","year":"2007","unstructured":"I\u015feri S, Ercan F, Gedik N et al (2007) Simvastatin attenuates cisplatin-induced kidney and liver damage in rats. Toxicology. https:\/\/doi.org\/10.1016\/j.tox.2006.11.073","journal-title":"Toxicology"},{"key":"5658_CR20","doi-asserted-by":"publisher","first-page":"218","DOI":"10.4103\/ijn.IJN_14_20","volume":"31","author":"L Jafaripour","year":"2021","unstructured":"Jafaripour L, Naserzadeh R, Alizamani E et al (2021) Effects of rosmarinic acid on methotrexate-induced nephrotoxicity and hepatotoxicity in Wistar rats. Indian J Nephrol 31:218\u2013224. https:\/\/doi.org\/10.4103\/ijn.IJN_14_20","journal-title":"Indian J Nephrol"},{"key":"5658_CR21","doi-asserted-by":"publisher","first-page":"123","DOI":"10.5551\/jat.12849","volume":"20","author":"WF Keane","year":"2013","unstructured":"Keane WF, Tomassini JE, Neff DR (2013) Lipid abnormalities in patients with chronic kidney disease: implications for the pathophysiology of atherosclerosis. J Atheroscler Thromb 20:123\u2013133. https:\/\/doi.org\/10.5551\/jat.12849","journal-title":"J Atheroscler Thromb"},{"key":"5658_CR22","doi-asserted-by":"publisher","first-page":"354","DOI":"10.4103\/0253-7613.115016","volume":"45","author":"R Maheshwari","year":"2013","unstructured":"Maheshwari R, Sailor G, Patel L, Balaraman R (2013) Amelioration of cisplatin-induced nephrotoxicity by statins. Indian J Pharmacol 45:354\u2013358. https:\/\/doi.org\/10.4103\/0253-7613.115016","journal-title":"Indian J Pharmacol"},{"key":"5658_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1491249","author":"NM Mahmoud","year":"2024","unstructured":"Mahmoud NM, Elshazly SM, El-shaarawy F et al (2024) Nitazoxanide mitigates methotrexate hepatotoxicity in rats: role in inhibiting apoptosis and regulating endoplasmic reticulum stress. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2024.1491249","journal-title":"Front Pharmacol"},{"key":"5658_CR24","doi-asserted-by":"publisher","DOI":"10.3897\/folmed.67.e143221","author":"P Markova","year":"2025","unstructured":"Markova P, Spasova M, Spasov N, Markov S (2025) Acute kidney injury after high-dose methotrexate application \u2013 case report. Folia Med (Plovdiv). https:\/\/doi.org\/10.3897\/folmed.67.e143221","journal-title":"Folia Med (Plovdiv)"},{"key":"5658_CR25","doi-asserted-by":"publisher","unstructured":"Morsy MA, Ibrahim SA, Amin EF, et al (2013) Curcumin ameliorates methotrexate-induced nephrotoxicity in rats. Adv Pharmacol Sci 2013:. https:\/\/doi.org\/10.1155\/2013\/387071","DOI":"10.1155\/2013\/387071"},{"key":"5658_CR26","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1161\/HYPERTENSIONAHA.113.01954","volume":"62","author":"AE Norlander","year":"2013","unstructured":"Norlander AE, Saleh MA, Madhur MS (2013) CXCL16: a chemokine-causing chronic kidney disease. Hypertension 62:1008\u20131010","journal-title":"Hypertension"},{"key":"5658_CR27","doi-asserted-by":"publisher","unstructured":"Pu J, Gao M, Yu P, et al (2024) Simvastatin reduces chronic kidney disease and renal failure risk in type 2 diabetes patients: post hoc ACCORD trial analysis. Diabetol Metab Synd 16:. https:\/\/doi.org\/10.1186\/s13098-024-01514-6","DOI":"10.1186\/s13098-024-01514-6"},{"key":"5658_CR28","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1007\/s00467-018-4061-9","volume":"34","author":"R Raina","year":"2019","unstructured":"Raina R, Krishnappa V (2019) An update on LDL apheresis for nephrotic syndrome. Pediatr Nephrol 34:1655\u20131669. https:\/\/doi.org\/10.1007\/s00467-018-4061-9","journal-title":"Pediatr Nephrol"},{"key":"5658_CR29","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/ki.2008.181","volume":"74","author":"A Schramme","year":"2008","unstructured":"Schramme A, Abdel-Bakky MS, Gutwein P et al (2008) Characterization of CXCL16 and ADAM10 in the normal and transplanted kidney. Kidney Int 74:328\u2013338. https:\/\/doi.org\/10.1038\/ki.2008.181","journal-title":"Kidney Int"},{"key":"5658_CR30","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1111\/j.1523-1755.2004.00512.x","volume":"65","author":"EM Simmons","year":"2004","unstructured":"Simmons EM, Himmelfarb J, Tugrul Sezer M et al (2004) Plasma cytokine levels predict mortality in patients with acute renal failure. Kidney Int 65:1357\u20131365. https:\/\/doi.org\/10.1111\/j.1523-1755.2004.00512.x","journal-title":"Kidney Int"},{"key":"5658_CR31","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.kint.2016.02.026","volume":"90","author":"ND Vaziri","year":"2016","unstructured":"Vaziri ND (2016) Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences. Kidney Int 90:41\u201352. https:\/\/doi.org\/10.1016\/j.kint.2016.02.026","journal-title":"Kidney Int"},{"key":"5658_CR32","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1177\/1078155215594417","volume":"22","author":"T Wiczer","year":"2016","unstructured":"Wiczer T, Dotson E, Tuten A et al (2016) Evaluation of incidence and risk factors for high-dose methotrexate-induced nephrotoxicity. J Oncol Pharm Pract 22:430\u2013436. https:\/\/doi.org\/10.1177\/1078155215594417","journal-title":"J Oncol Pharm Pract"},{"key":"5658_CR33","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1093\/ndt\/gfg143","volume":"18","author":"SH Wilson","year":"2003","unstructured":"Wilson SH, Chade AR, Feldstein A et al (2003) Lipid-lowering-independent effects of simvastatin on the kidney in experimental hypercholesterolaemia. Nephrol Dial Transplant 18:703\u2013709. https:\/\/doi.org\/10.1093\/ndt\/gfg143","journal-title":"Nephrol Dial Transplant"},{"key":"5658_CR34","doi-asserted-by":"publisher","unstructured":"Wu T, Xie C, Wang HW, et al (2007) Elevated urinary VCAM-1, P-Selectin, soluble TNF receptor-1, and CXC chemokine ligand 16 in multiple murine lupus strains and human lupus Nephritis1 179(10):7166\u201375. https:\/\/doi.org\/10.4049\/jimmunol.179.10.7166.","DOI":"10.4049\/jimmunol.179.10.7166"},{"key":"5658_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/nature01158","author":"S Youssef","year":"2002","unstructured":"Youssef S, St\u00fcve O, Patarroyo JO et al (2002) The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Nature. https:\/\/doi.org\/10.1038\/nature01158","journal-title":"Nature"},{"key":"5658_CR36","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1177\/0960327116637414","volume":"36","author":"Y Yuksel","year":"2017","unstructured":"Yuksel Y, Yuksel R, Yagmurca M et al (2017) Effects of quercetin on methotrexate-induced nephrotoxicity in rats. Hum Exp Toxicol 36:51\u201361. https:\/\/doi.org\/10.1177\/0960327116637414","journal-title":"Hum Exp Toxicol"},{"key":"5658_CR37","doi-asserted-by":"publisher","first-page":"4460","DOI":"10.3892\/etm.2017.5023","volume":"14","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Rong S, Feng Y et al (2017) Simvastatin attenuates renal ischemia\/reperfusion injury from oxidative stress via targeting Nrf2\/HO-1 pathway. Exp Ther Med 14:4460\u20134466. https:\/\/doi.org\/10.3892\/etm.2017.5023","journal-title":"Exp Ther Med"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05658-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05658-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05658-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T23:02:36Z","timestamp":1792882956000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05658-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":37,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["5658"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05658-2","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,2]]},"assertion":[{"value":"22 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments were conducted in accordance with NIH guidelines (Eighth edition of Guide for the Care and Use of Laboratory Animals). All methods and procedures used in this experimental research were reviewed and authorized by Qassim University\u2019s ethical committee with number (25\u201315-01) dated December 1, 2025.","order":1,"name":"Ethics","label":"Ethical considerations","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}